Home
About
Overview
Sharing Data
ORCID
Help
History (13)
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer.
Computer-aided diagnosis to distinguish benign from malignant solitary pulmonary nodules on radiographs: ROC analysis of radiologists' performance--initial experience.
Peginterferon alpha-2a combination therapies in chronic hepatitis C patients who relapsed after or had a viral breakthrough on therapy with standard interferon alpha-2b plus ribavirin: a pilot study of efficacy and safety.
Age-dependent chromosomal distribution of male-biased genes in Drosophila.
High-dose statin therapy: benefits and safety in aggressive lipid lowering.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
High-dose statin therapy: benefits and safety in aggressive lipid lowering.
High-dose statin therapy: benefits and safety in aggressive lipid lowering. J Fam Pract. 2008 May; 57(5 Suppl High-Dose):S29-36.
View in:
PubMed
subject areas
Cardiovascular Diseases
Cholesterol, LDL
Clinical Trials as Topic
Dose-Response Relationship, Drug
Evidence-Based Medicine
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypercholesterolemia
Male
Risk Factors
authors with profiles
Michael H. Davidson